CrossRefPubMed 6 Yano M, Ikeda Y, Matsuzaki M: Altered intracell

CrossRefPubMed 6. Yano M, Ikeda Y, Matsuzaki M: Altered intracellular Ca2+ handling in heart failure. J Clin Invest 2005, 115: 556–64.PubMed 7. Kellner Vadimezan J, Tantzscher J, Oelmez H, Edelmann M, Fischer R, Huber RM, Bergner A: Mechanisms Altering Airway Smooth Muscle Cell Ca Homeostasis in Two Asthma Models. Respiration 2008, 76: 205–15.CrossRefPubMed 8. Korosec B, Glavac D, Rott T, Ravnik-Glavac M: Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet Cytogenet 2006, 171: 105–11.CrossRefPubMed 9. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, Tanzawa H: Sarcoendoplasmic reticulum

Ca(2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 2004, 110: 225–31.CrossRefPubMed 10. Pacifico F, Ulianich L, De Micheli S, Treglia S, Leonardi A, Vito P, Formisano S, Consiglio E, Di Jeso B: The expression of the sarco/endoplasmic reticulum Ca2+-ATPases in thyroid and its down-regulation following neoplastic transformation. J Mol Endocrinol 2003, 30: 399–409.CrossRefPubMed 11. Brouland JP, Gelebart

P, Kovacs T, Enouf J, Grossmann J, Papp B: The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis. Am J Pathol 2005, 167: 233–42.PubMed 12. Chung FY, Lin SR, Lu CY, Yeh CS, Chen FM, Hsieh JS, Huang TJ, Wang JY: Sarco/endoplasmic Apoptosis inhibitor reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer. Am J Surg Pathol 2006, 30: 969–74.CrossRefPubMed 13. Legrand G, Humez S, Slomianny C, Dewailly E, Abeele F, Mariot P, CRM1 inhibitor Wuytack F, Prevarskaya N: Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases Amino acid 2B involvement in human prostate cancer cell growth control. J Biol Chem 2001, 276: 47608–14.CrossRefPubMed 14. Vanoverberghe K, Abeele F, Mariot

P, Lepage G, Roudbaraki M, Bonnal JL, Mauroy B, Shuba Y, Skryma R, Prevarskaya N: Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ 2004, 11: 321–30.CrossRefPubMed 15. Crepin A, Bidaux G, Abeele F, Dewailly E, Goffin V, Prevarskaya N, Slomianny C: Prolactin stimulates prostate cell proliferation by increasing endoplasmic reticulum content due to SERCA 2b over-expression. Biochem J 2007, 401: 49–55.CrossRefPubMed 16. Lipskaia L, Hulot JS, Lompre AM: Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflugers Arch 2009, 457 (3) : 673–85.CrossRefPubMed 17. Bezprozvanny I: The inositol 1,4,5-trisphosphate receptors. Cell Calcium 2005, 38: 261–72.CrossRefPubMed 18. Sakakura C, Hagiwara A, Fukuda K, Shimomura K, Takagi T, Kin S, Nakase Y, Fujiyama J, Mikoshiba K, Okazaki Y, Yamagishi H: Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res 2003, 23: 3691–7.PubMed 19.

Comments are closed.